Company intelligence
ExcellGene SA
We are a CDMO providing Swiss quality cell line development and protein expression services. Expect Great Science.
About ExcellGene SA
Looking for a trusted partner in the development of cell lines and manufacturing processes? Look no further. With over 20 years of experience, we specialize in high-yielding (5-14 g/L), GMP-ready, CHO, and HEK293 cell lines for the production of biologics, biosimilars, and gene therapy (AAV, Adenovirus). We have a proven track record of expressing all types of proteins, including bi-specific mAb, Fc-fusions, viral proteins, cytokines, and more. Our team of scientists is ready to support your project from start to finish, including process development, analytical methods, scale-up, tox-batches, and Master Cell Banking. At our company, we pride ourselves on our commitment to quality and customer satisfaction. Contact us today to see how we can help you achieve your goals and be your trusted partner in cell line and process development.
Verified activity
Signals from ExcellGene SA
2 published signals
Presence & Recognition
ExcellGene SA team will be at CPHI Milan 2026 at Booth 12J21 from 6-8 October 2026 to connect with partners, clients, and biosimilar pipeline discussions.
Reported by ExcellGene SA
People
ExcellGene SA welcomed Luca Valeggia as the new CEO of ExcellGene Group.
Reported by ExcellGene SA